share_log

信義玻璃:翌日披露報表

XINYI GLASS: Next Day Disclosure Return

HKEX ·  Aug 7 07:23

Summary by Moomoo AI

信義玻璃(00868.HK)於2024年8月7日提交了新的翌日披露報表,披露其已發行股份數目出現變動。根據報表,該公司於2024年7月31日的已發行股份為4,224,536,272股,而在2024年8月7日,信義玻璃根據截至2023年12月31日止年度的末期股息以股代息計劃,發行了517,412股新股,使得已發行股份數目增至4,225,053,684股。該次發行的代息股份每股發行價為8.84港元。公司確認,所有股份發行或庫存股份出售或轉讓均已獲得董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。
信義玻璃(00868.HK)於2024年8月7日提交了新的翌日披露報表,披露其已發行股份數目出現變動。根據報表,該公司於2024年7月31日的已發行股份為4,224,536,272股,而在2024年8月7日,信義玻璃根據截至2023年12月31日止年度的末期股息以股代息計劃,發行了517,412股新股,使得已發行股份數目增至4,225,053,684股。該次發行的代息股份每股發行價為8.84港元。公司確認,所有股份發行或庫存股份出售或轉讓均已獲得董事會正式授權批准,並遵守所有適用的上市規則、法律及其他監管規定。
Xinyi Glass (00868.HK) submitted a new disclosure report on August 7, 2024, disclosing changes in the number of issued shares. According to the report, the company had 4,224,536,272 issued shares as of July 31, 2024. On August 7, 2024, in accordance with the end-of-year dividend-in-shares plan for the year ended December 31, 2023, Xinyi Glass issued 517,412 new shares, increasing the number of issued shares to 4,225,053,684. The dividend shares issued each had an issue price of HKD 8.84. The company confirmed that all share issuance or sale of treasury stocks or transfers had been formally authorized by the board of directors and complied with all applicable listing rules, laws, and other regulatory requirements.
Xinyi Glass (00868.HK) submitted a new disclosure report on August 7, 2024, disclosing changes in the number of issued shares. According to the report, the company had 4,224,536,272 issued shares as of July 31, 2024. On August 7, 2024, in accordance with the end-of-year dividend-in-shares plan for the year ended December 31, 2023, Xinyi Glass issued 517,412 new shares, increasing the number of issued shares to 4,225,053,684. The dividend shares issued each had an issue price of HKD 8.84. The company confirmed that all share issuance or sale of treasury stocks or transfers had been formally authorized by the board of directors and complied with all applicable listing rules, laws, and other regulatory requirements.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more